CELL Series: Understanding the Role of Biomarkers in Personalized Healthcare for Cancer

Identifying biomarkers in a patient’s tumor tissue or blood is an essential step in developing a personalized treatment plan, which might include targeted medicines or immunotherapies. However, not all patients receive biomarker testing, or tests for all possible biomarkers. There are multiple reasons for today’s biomarker testing gaps, including lack of awareness, inadequate insurance coverage, and practical challenges such as long turn-around times for results. Learn more about biomarkers and biomarker testing in this fast-paced introduction session.

Featuring:

Carol Fier, MSN Principal Medical Science Liaison, Lung, GU and Derm Oncology, US Medical Affairs, Genentech

Emily Driver, PhD Senior Medical Science Liaison, Breast, GI, & Gynecological Oncology, US Medical Affairs, Genentech

Mary Halloran, PharmD, BCPS Principal Medical Science Liaison, Malignant Hematology, US Medical Affairs, Genentech

Register here.